第　93　巻　索　引,,,
1,,,
(1→3) β-D-glucan,500,,
A,,,
abscess,520,,
acute kidney injury,643,,
ampicillin,649,,
antibiotics treatment duration,659,,
antimicrobial stewardship,25,,
antimicrobial stewardship program,306,,
antimicrobials,643,,
autopsy,139,,
B,,,
bacteremia,659,759,
blood crust,21,,
C,,,
Campylobacter gracilis,520,,
capsular typing,507,,
carbapenem-resistant Enterobacteriaceae,125,,
carbapenemase,125,,
catheter-related blood stream infection,515,,
child,485,643,
cloxacillin,649,,
community acquired infection,125,,
confirmatory test,12,,
Corynebacterium striatum,326,,
Cutibacterium acnes,330,,
D,,,
daptomycin,326,,
disseminated cryptococcosis,139,,
E,,,
empiric therapy,649,,
enterohemorrhagic Escherichia coli (EHEC),655,,
extended spectrum β―lactamase (ESBL),18,,
extended-spectrum β-lactamase (ESBL) - producing bacteria,125,,
F,,,
false positive,500,,
Fusobacterium nucleatum,768,,
G,,,
genetic analysis,319,,
Gram staining,306,,
H,,,
health insurance claim,25,,
Helicobacter cinaedi,659,,
human immunodeficiency virus type 1 (HIV-1),12,298,312
human immunodeficiency virus type 2 (HIV-2),12,,
hypervirulent Klebsiella pneumoniae,319,,
I,,,
immune reconstitution inflammatory syndrome,775,,
infection control,655,,
infective endocarditis,649,,
infiltration,330,,
influenza,132,,
integrase strand transfer inhibitor,312,,
invasive fungal infection,500,,
invasive pneumococcal disease,485,763,
J,,,
Japanese spotted fever,21,525,
L,,,
laboratory-acquired infection,655,,
liver abscess,319,,
M,,,
measles,1,,
mediastinitis,330,,
meropenem,520,,
multiple cerebral nerve palsy,775,,
Mycoplasm pneumoniae pneumonia,643,,
N,,,
non-vaccine serotype,763,,
P,,,
package insert,25,,
penicillin-susceptible enterococci,306,,
pneumococcal conjugate vaccine,485,,
polymerase chain reaction (PCR),21,,
portal vein thrombosis,768,,
pylephlebitis,768,,
R,,,
real-time PCR,507,,
respiratory failure,139,,
Rhodococcus corynebacterioides,759,,
rubella,1,,
S,,,
seroepidemiology,1,,
serotype replacement,485,763,
Shigella sonnei,18,,
Streptococcus agalactiae (GBS),507,,
subtype,298,,
subtype B,312,,
sudden infant death syndrome (SIDS),493,,
supportive treatment,525,,
surveillance,298,312,
T,,,
tetracycline,525,,
tosufloxacin tosilate,643,,
transmitted drug resistance (TDR),298,312,
travel medicine,132,,
travelers diarrhea,18,,
tropical diseases,132,,
V,,,
vaccination,1,,
vaccine,493,,
vaccine adverse event,493,,
vaccine adverse event reporting system (VAERS),493,,
vaccine adverse reaction,493,,
varicella zoster virus,775,,
W,,,
western blot,12,,
Y,,,
Yarrowia lipolytica,515,,